Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 4Neuroendocrine Tumors 2Lymphoma 2Hodgkin Disease 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Smoking Cessation 1Rectal Neoplasms 1Prostate Cancer Metastatic 1Neoplastic Cells, Circulating 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Pulmonary Nodules 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Leukemia 1Hypoxia 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Lobular 1Cancer Diagnosis 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Cyclophosphamide 178Cytarabine 110fludarabine phosphate 102Methotrexate 98Busulfan 90Filgrastim 80Rituximab 72Peripheral Blood Stem Cell Transplantation 69Cyclosporine 60Radiotherapy 57Etoposide 57Mycophenolic Acid 56Antilymphocyte Serum 56fludarabine 55Tacrolimus 55Vincristine 47Whole-Body Irradiation 44Melphalan 42Dexamethasone 39Granulocyte Colony-Stimulating Factor 38sargramostim 34Methylprednisolone 34Alemtuzumab 34Daunorubicin 33Imatinib Mesylate 32Mercaptopurine 28Prednisone 26Idarubicin 26Doxorubicin 25Leucovorin 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia × Positron Emission Tomography Computed Tomography × Clear all
NCT01920737 2025-09-16

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
39 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡